Lokal ileri evre meme kanserli hastalarda neoadjuvan kemoterapinin ER, PR, c-erb2, VEGF ve Ki-67 üzerine etkisi

Author:

Sarıtaş Ahmet Gökhan,Yalav Orçun,Kekeç Yalçın,Sakman Gürhan,Kılıç Emine,Zorludemir Suzan,Ergin Melek,Eray İsmail Cem,Kara Oğuz,Paydaş Semra

Publisher

Cukurova Medical Journal

Subject

General Earth and Planetary Sciences,General Environmental Science

Reference22 articles.

1. 1. Jatoi I. Breast cancer: a systemic or local disease? Am J ClinOncol 1997; 20(5):536-9.

2. 2. Güler N, Karabulut B, Koçdor MA, Kaya H, Esen G, Özaslan C, Saip P, Görken İ. Locally Advanced Breast Cancer-2010 Istanbul breast cancer Consensus Meeting. The Journal of Breast Health 2011:7(2);68-85.

3. 3. Edge SB, Byrd DR, Compton CC, Fritz AG, Grene FI, Trotti A (Eds). Breast in AJCC Cancer Staging Manual. Seventh Edition. Springer, Chicago, IL 2010:345-377

4. 4. Kim EA, Gershtein ES, Vyotskaya IV, Kushlinskii NE. Expression of VEGF and VEGFR2 in tumors during neoadjuvant therapy of patients with breast cancer. Bull Exp Biol Med. 2008;145(2):245-8.

5. 5. Burcombe RJ, Makris A, Richman PI, Daley FM, Noble S, Pittam M, Wright D, Allen SA, Dove J, Wilson D. Evaluation of ER, PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer. Br J Cancer 2005;92(1):147-55.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3